Science Explorer Back to mapMap
Discussion
Hospital / health system · Cardiff · United Kingdom

Velindre Cancer Centre

In research, Velindre Cancer Centre stands highest in Health Sciences (#4,523 of 16,688 worldwide) and Medicine (#4,279 of 14,558 worldwide), over all time. Relative to its size it is most specialised in Medicine and Health Sciences (Medicine is 3.9× its share of world research).

velindrecc.wales.nhs.uk/homeROR OpenAlex
World rank, all time
#14,011
of 34,923
Rank in United Kingdom
#697
of 1,844
Research works
623
▼ 21% vs 2018-21
Citations
15k
24.4 per fractional work
Top-10% rate
9.1%
all institutions 10.0%
vs its own fields
0.99×
1.00× is exactly expected
Open access
30%
world 40%
International
14%
world 18%
Velindre Cancer Centre

What is Velindre Cancer Centre known for in research?

The fields where it stands highest, over all time, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorks
Health SciencesDomain #4,523 of 16,688 9.6%455
MedicineField #4,279 of 14,558 9.8%432

Each strip is that field's whole ranked pool, with the notch where Velindre Cancer Centre sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no average mark, because the average differs by field (from about 6% in Dentistry to 21% in Economics).

Which fields of science does Velindre Cancer Centre work in?

In 2022-now, 79% of research at Velindre Cancer Centre is in Health Sciences, 11% in Life Sciences. Its largest fields are Medicine (75%), Biochemistry, Genetics and Molecular Biology (9%), Health Professions (4%). It does 3.0× the world's share of Health Sciences.

Health Sciences: 47 fractional works · 79.1% of its workMedicine: 44 fractional works · 74.7% of its workPulmonary and Respiratory Medicine: 12 fractional works · 19.8% of its workOncology: 11 fractional works · 18.9% of its workSurgery: 5 fractional works · 8.7% of its workRadiology, Nuclear Medicine and Imaging: 4 fractional works · 6.5% of its workPublic Health, Environmental and Occupational Health: 2 fractional works · 3.0% of its workPathology and Forensic Medicine: 1 fractional works · 2.5% of its workEpidemiology: 1 fractional works · 1.6% of its workEndocrinology, Diabetes and Metabolism: 1 fractional works · 1.5% of its workHepatology: 1 fractional works · 1.2% of its workEmergency Medicine: 1 fractional works · 1.1% of its workHealth Informatics: 1 fractional works · 1.1% of its workObstetrics and Gynecology: 1 fractional works · 0.9% of its workGenetics: 0 fractional works · 0.8% of its workGeriatrics and Gerontology: 0 fractional works · 0.8% of its workCardiology and Cardiovascular Medicine: 0 fractional works · 0.6% of its workHematology: 0 fractional works · 0.6% of its workOtorhinolaryngology: 0 fractional works · 0.6% of its workPhysiology: 0 fractional works · 0.6% of its workReproductive Medicine: 0 fractional works · 0.5% of its workNeurology: 0 fractional works · 0.5% of its workInternal Medicine: 0 fractional works · 0.5% of its workDermatology: 0 fractional works · 0.4% of its workRheumatology: 0 fractional works · 0.3% of its workOphthalmology: 0 fractional works · 0.3% of its workPediatrics, Perinatology and Child Health: 0 fractional works · 0.3% of its workSmaller subfields together: 1 fractional works · 1.2% of its workHealth Professions: 2 fractional works · 4.1% of its workGeneral Health Professions: 2 fractional works · 3.5% of its workRadiological and Ultrasound Technology: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.3% of its workNursing: 0 fractional works · 0.2% of its workVeterinary: 0 fractional works · 0.1% of its workLife Sciences: 6 fractional works · 10.6% of its workBiochemistry, Genetics and Molecular Biology: 5 fractional works · 8.6% of its workCancer Research: 2 fractional works · 3.0% of its workMolecular Biology: 1 fractional works · 2.3% of its workGenetics: 1 fractional works · 2.0% of its workBiotechnology: 0 fractional works · 0.5% of its workCell Biology: 0 fractional works · 0.3% of its workBiophysics: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.2% of its workImmunology and Microbiology: 1 fractional works · 1.5% of its workImmunology: 1 fractional works · 1.4% of its workSmaller subfields together: 0 fractional works · 0.1% of its workPharmacology, Toxicology and Pharmaceutics: 0 fractional works · 0.2% of its workNeuroscience: 0 fractional works · 0.2% of its workPhysical Sciences: 4 fractional works · 6.0% of its workEngineering: 1 fractional works · 1.9% of its workBiomedical Engineering: 1 fractional works · 1.5% of its workMedia Technology: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.1% of its workComputer Science: 1 fractional works · 1.4% of its workComputer Vision and Pattern Recognition: 0 fractional works · 0.4% of its workInformation Systems: 0 fractional works · 0.4% of its workArtificial Intelligence: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.2% of its workPhysics and Astronomy: 1 fractional works · 1.3% of its workRadiation: 1 fractional works · 1.2% of its workSmaller subfields together: 0 fractional works · 0.1% of its workMathematics: 0 fractional works · 0.7% of its workStatistics and Probability: 0 fractional works · 0.7% of its workMaterials Science: 0 fractional works · 0.5% of its workMaterials Chemistry: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.2% of its workChemistry: 0 fractional works · 0.1% of its workEnvironmental Science: 0 fractional works · 0.1% of its workSocial Sciences: 3 fractional works · 4.3% of its workSocial Sciences: 1 fractional works · 1.5% of its workDemography: 0 fractional works · 0.6% of its workSociology and Political Science: 0 fractional works · 0.5% of its workEducation: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.2% of its workEconomics, Econometrics and Finance: 1 fractional works · 1.3% of its workEconomics and Econometrics: 1 fractional works · 1.3% of its workPsychology: 1 fractional works · 1.3% of its workSocial Psychology: 0 fractional works · 0.5% of its workApplied Psychology: 0 fractional works · 0.3% of its workClinical Psychology: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.1% of its workBusiness, Management and Accounting: 0 fractional works · 0.2% of its workDecision Sciences: 0 fractional works · 0.1% of its workALL ITS WORKVelindre CancerCentre60fractional works, 2022-now
Life Sciences11%Physical Sciences6%Health Sciences79%Social Sciences4%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 20 fields, with their numbers
    1. Medicine4474.7%
    2. Health Professions24.1%
    3. Nursing00.2%
    4. Veterinary00.1%
    1. Biochemistry, Genetics and Molecular Biology58.6%
    2. Immunology and Microbiology11.5%
    3. Pharmacology, Toxicology and Pharmaceutics00.2%
    4. Neuroscience00.2%
    1. Engineering11.9%
    2. Computer Science11.4%
    3. Physics and Astronomy11.3%
    4. Mathematics00.7%
    5. Materials Science00.5%
    6. Chemistry00.1%
    7. Environmental Science00.1%
    1. Social Sciences11.5%
    2. Economics, Econometrics and Finance11.3%
    3. Psychology11.3%
    4. Business, Management and Accounting00.2%
    5. Decision Sciences00.1%
All of science, and how each field's share has moved since 1950: the Science domain explorer

What does Velindre Cancer Centre specialise in?

Where its research is concentrated relative to its size: Medicine takes 3.9× the share of its output that it takes of world research.

  1. MedicineField · 44.5 works3.9×
  2. Health SciencesDomain · 47.1 works3.5×
← less than its size predicts1×more →

Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 1.61× its world share, 5 worksBiochemistry, Geneti…Immunology and Microbiology: 1.54× its world share, 1 worksImmunology and Micro…Neuroscience: 0.12× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 0.67× its world share, 0 worksPharmacology, Toxico…Chemistry: 0.08× its world share, 0 worksChemistryComputer Science: 0.18× its world share, 1 worksComputer ScienceEngineering: 0.13× its world share, 1 worksEngineeringEnvironmental Science: 0.02× its world share, 0 worksEnvironmental ScienceMaterials Science: 0.13× its world share, 0 worksMaterials ScienceMathematics: 0.61× its world share, 0 worksMathematicsPhysics and Astronomy: 0.57× its world share, 1 worksPhysics and AstronomyHealth Professions: 1.57× its world share, 2 worksHealth ProfessionsMedicine: 3.89× its world share, 44 worksMedicineNursing: 0.38× its world share, 0 worksNursingVeterinary: 0.92× its world share, 0 worksVeterinaryBusiness, Management and Accounting: 0.06× its world share, 0 worksBusiness, Management…Decision Sciences: 0.05× its world share, 0 worksDecision SciencesEconomics, Econometrics and Finance: 0.62× its world share, 1 worksEconomics, Econometr…Psychology: 0.41× its world share, 1 worksPsychologySocial Sciences: 0.12× its world share, 1 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 3.9×. Every wedge is a field page.

All 20 fields, with their numbers
  1. Medicine3.89×44 works
  2. Biochemistry, Genetics and Molecular Biology1.61×5 works
  3. Health Professions1.57×2 works
  4. Immunology and Microbiology1.54×1 works
  5. Veterinary0.92×0 works
  6. Pharmacology, Toxicology and Pharmaceutics0.67×0 works
  7. Economics, Econometrics and Finance0.62×1 works
  8. Mathematics0.61×0 works
  9. Physics and Astronomy0.57×1 works
  10. Psychology0.41×1 works
  11. Nursing0.38×0 works
  12. Computer Science0.18×1 works
  13. Engineering0.13×1 works
  14. Materials Science0.13×0 works
  15. Neuroscience0.12×0 works
  16. Social Sciences0.12×1 works
  17. Chemistry0.08×0 works
  18. Business, Management and Accounting0.06×0 works
  19. Decision Sciences0.05×0 works
  20. Environmental Science0.02×0 works

Who are the top researchers at Velindre Cancer Centre?

Ranked on the quality score, Simon Gollins, Jason Francis Lester and Simon H. Waters lead among researchers whose main affiliation is Velindre Cancer Centre.

  1. 1 Simon Gollins United Kingdom · #88,535 worldwide 8.6k citations · 200 works
  2. 2 Jason Francis Lester United Kingdom · #178,791 worldwide 17k citations · 195 works
  3. 3 Simon H. Waters United Kingdom · #228,964 worldwide 3.1k citations · 79 works
  4. 4 Mererid Evans United Kingdom · #235,187 worldwide 6.5k citations · 85 works
  5. 5 Peter J. Barrett-Lee United Kingdom · #389,291 worldwide 10k citations · 204 works
  6. 6 Jacinta Abraham United Kingdom · #458,677 worldwide 2.8k citations · 36 works
  7. 7 Emma R. Hudson United Kingdom · #478,196 worldwide 3.6k citations · 68 works
  8. 8 Annabel Borley United Kingdom · #482,822 worldwide 1.2k citations · 38 works
  9. 9 Jim Barber United Kingdom · #578,037 worldwide 1.7k citations · 42 works
  10. 10 Tom David Lewis Crosby United Kingdom · #618,379 worldwide 7.9k citations · 199 works
All ranked researchers at Velindre Cancer Centre

What are the most cited papers from Velindre Cancer Centre?

The most cited paper from Velindre Cancer Centre is "Abiraterone and Increased Survival in Metastatic Prostate Cancer" (Johann Sebastian De Bono et al., 2011), with 4,448 citations. Next come "EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent" (3,282) and "EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer—2020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent" (2,876).

Most cited papers
#PaperReleasedCitations
1 Abiraterone and Increased Survival in Metastatic Prostate Cancer Johann Sebastian De Bono et al. · New England Journal of Medicine Open access 25 May 2011 4,448
2 EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent Nicolas Mottet et al. · European Urology Open access 31 Aug 2016 3,282
3 EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer—2020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent Nicolas Mottet et al. · European Urology Open access 7 Nov 2020 2,876
4 PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer Antonino Glaviano et al. · Molecular Cancer Open access 18 Aug 2023 2,108
5 Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial Nicholas David James et al. · The Lancet Open access 21 Dec 2015 1,985
All 60 most cited papers, with filters and sorting

Which keywords describe research at Velindre Cancer Centre?

By fractional works in 2022-now, weighted toward what it does more of than the world: Chemotherapy, Immunotherapy, Radiotherapy, Targeted Therapy, Clinical Trials, Clinical Practice Guidelines, Prognostic Factors and Breast Cancer.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Chemotherapy8▲ 19×21 topics
  2. Immunotherapy6▲ 13×14 topics
  3. Radiotherapy5▲ 22×11 topics
  4. Targeted Therapy5▲ 36×4 topics
  5. Clinical Trials5▲ 12×6 topics
  6. Clinical Practice Guidelines4▲ 11×9 topics
  7. Breast Cancer4▲ 24×10 topics
  8. Prognostic Factors4▲ 14×12 topics
  9. Genomic Profiling4▲ 56×2 topics
  10. Quality of Life3▲ 4.0×14 topics
  11. Tumor Microenvironment3▲ 13×7 topics
  12. Survival Analysis3▲ 20×6 topics
  13. Genetic Mutations3▲ 12×9 topics
  14. Adjuvant Therapy3▲ 39×2 topics
  15. Biomarkers3▲ 6.8×5 topics
  16. Endoscopic Resection3▲ 48×2 topics
  17. Molecular Characterization3▲ 27×4 topics
  18. Treatment3▲ 3.7×13 topics
  19. Neoadjuvant Therapy3▲ 19×5 topics
  20. Precision Medicine3▲ 8.7×5 topics
  21. Treatment Guidelines2▲ 18×2 topics
  22. ALK Inhibitors2▲ 63×1 topic
  23. EGFR Mutations2▲ 63×1 topic
  24. Immune Checkpoint Blockade2▲ 32×1 topic
  25. Metastatic Breast Cancer2▲ 64×2 topics
  26. PD-1 and PD-L12▲ 32×1 topic
  27. Cancer Therapy2▲ 6.2×7 topics
  28. Gastric Cancer2▲ 32×3 topics
  29. Surgery2▲ 10×6 topics
  30. Clinical Guidelines2▲ 11×4 topics
  31. Meta-Analysis2▲ 5.8×3 topics
  32. Prostate Cancer2▲ 25×3 topics
  33. Tumor Staging2▲ 29×2 topics
  34. Cancer Treatment2▲ 13×4 topics
  35. Chemoradiation2▲ 48×2 topics
  36. Preoperative Chemoradiotherapy2▲ 40×2 topics
  37. Medical Education2▲ 11×4 topics
  38. Metastatic2▲ 47×2 topics
  39. Metastasis2▲ 8.6×7 topics
  40. CT Screening2▲ 40×1 topic

Which research topics does Velindre Cancer Centre publish most on?

By volume in 2022-now: Lung Cancer Treatments and Mutations, Cancer Immunotherapy and Biomarkers, Lung Cancer Diagnosis and Treatment and Esophageal Cancer Research and Treatment.

Lung Cancer Treatments a…2Lung Cancer Treatments and Mutations: 2 fractional worksCancer Immunotherapy and…2Cancer Immunotherapy and Biomarkers: 2 fractional worksLung Cancer Diagnosis and Treatment: 2 fractional worksEsophageal Cancer Research and Treatment: 2 fractional worksAdvances in Oncology and Radiotherapy: 2 fractional worksAdvanced Breast Cancer Therapies: 1 fractional worksGastric Cancer Management and Outcomes: 1 fractional worksCancer Genomics and Diag…1Cancer Genomics and Diagnostics: 1 fractional worksProstate Cancer Treatment and Research: 1 fractional worksRenal cell carcinoma treatment: 1 fractional works
Pulmonary and Respiratory MedicineOncologySurgeryRadiology, Nuclear Medicine and Imaging1 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 2 works
  2. 2 Cancer Immunotherapy and Biomarkers Oncology 2 works
  3. 3 Lung Cancer Diagnosis and Treatment Pulmonary and Respiratory Medicine 2 works
  4. 4 Esophageal Cancer Research and Treatment Surgery 2 works
  5. 5 Advances in Oncology and Radiotherapy Radiology, Nuclear Medicine and Imaging 2 works
  6. 6 Advanced Breast Cancer Therapies Pulmonary and Respiratory Medicine 1 works
  7. 7 Gastric Cancer Management and Outcomes Pulmonary and Respiratory Medicine 1 works
  8. 8 Cancer Genomics and Diagnostics Cancer Research 1 works
  9. 9 Prostate Cancer Treatment and Research Pulmonary and Respiratory Medicine 1 works
  10. 10 Renal cell carcinoma treatment Pulmonary and Respiratory Medicine 1 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available30.5%not open69.5%

World: 40% of research is openly available.

with international co-authors14.1%domestic only85.9%

World: 18% is written across borders.

How has Velindre Cancer Centre's research output changed?

Output in 2022-2025 was 21% lower than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Velindre Cancer Centre as a percentage of every work published that year, 0.00022% in 2024.

still counting0.0010%0.0020%0.0030%Velindre Cancer Centre0.00026% in 202519801990200020102020

Fractional works of Velindre Cancer Centre over all fractional works that year. How the balance of science has shifted.

How much of it reaches the world top 10%

Year by year, against all institutions in the same year.

10%20%30%Velindre Cancer Centre11.5% in 2019all institutions10.0% in 20192010

Of each year's output, the share that reached the world's 10% most cited for its field and year. Peak 20.2% in 2013.

Other research institutions in Cardiff

All research institutions in Cardiff

Share Velindre Cancer Centre's ranking

Velindre Cancer Centre on Science Explorer

A card with Velindre Cancer Centre's standing and the fields it leads in, for a post or a slide. A link to this page previews as the same card.

Download the card

1200 × 630 PNG, sized for social posts, drawn from the latest snapshot.

Badges for a website1Each links back here and updates with every snapshot

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Velindre Cancer Centre. Posts are plain text and can be reported.